Stay updated with breaking news from Tyvaso remodulin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Corporation (NASDAQ:UTHR) Q4 2023 Earnings Call Transcript February 21, 2024 United Therapeutics Corporation beats earnings expectations. Reported EPS is $4.36, expectations were $3.92. United Therapeutics Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […] ....